Drug delivery supply chains can become complicated quickly. Every handoff adds time, cost, communication risk, quality risk, and accountability gaps. Medbio’s model is built to reduce that complexity.

Enrolling a large number of healthy travelers into a fixed-budget study without sites puts two pressures on the operation: the volume of lead handoffs and the interest that fades while a pre-qualified ...

A single swap, say a fluoropolymer gasket or filter, can force requalification, validation and refiling. Fluorine sits in a meaningful share of APIs, and fluoropolymers run through tubing, stoppers, ...

For the better part of a decade, the default advice handed to medtech founders planning a first-in-human (FIH) study fit in three words: go to Australia. The pitch was seductive and, for a while, ...

A clean GLP audit or a smooth pre-IND interaction feels like proof of control, yet companies that pass inspections still hit submission delays and longer diligence cycles as programs advance. The ...

AI-assisted drafting of CAPAs, deviation write-ups, and regulatory correspondence is probably already happening on your quality team, with no policy and no record. This paper argues the exposure is ...

A clean audit does not necessarily mean a medical device company is prepared for its next submission, product launch, or acquisition. Teams may pass audits consistently while still reconstructing ...

Familiarity can make manual quality systems look sturdier than they are. Spreadsheets, shared drives, and siloed eQMS platforms may feel dependable until an inspector starts tracing a document history ...

PFAS exposure for device manufacturers no longer hinges on a single rule or a single material. FDA has drawn a firmer line around fluoropolymers, yet state reporting requirements, a still-evolving EU ...

Many drug–device combination products can be developed to achieve the therapeutic goal and still face significant challenges in the manufacturing phase. Laboratory performance might be different from ...

Most quality leaders recognize the symptoms: audit prep that takes weeks, CAPAs that run past due, training records that are slow to retrieve. The harder question is where the system actually sits on ...

Manual gap analysis can consume significant quality and regulatory resources while still leaving organizations uncertain about inspection readiness. AI-based scanning, pre-validated framework maps for ...